SunTrust Robinson analyst Youssef Squali maintained a Buy rating on Cardlytics Inc (CDLX) today and set a price target of $25. The company’s shares opened today at $16.65.
Squali said:
“We maintain a Buy/$25 PT for CDLX ahead of 1Q results on 5/9. We expect CDLX to report an in line quarter with ~10% Y/Y revenue growth against mgmt’s guidance of $34.5-36.5M. We also expect mgmt to provide better visibility into the upcoming ramp in Y/Y revenue growth later this year, given the addition of JPM and Wells, and the big ramp in MAUs. While monetization growth has proven slower than expected since IPO, we continue to believe that it will materialize given Cardlytics’ effective and differentiated offering to marketers. on our FY19 ests, we find the stock compelling. 1Q19 Print. We are expecting revenue and adj. EBITDA of $36.1M/($6.3) vs. Street expectations of $36.1M/($5.8M), and vs. management guidance of $34.5-36.5M. Our estimates imply a ~10% Y/ Y growth rate.”
According to TipRanks.com, Squali is a top 100 analyst with an average return of 24.2% and a 72.6% success rate. Squali covers the Technology sector, focusing on stocks such as Match Group Inc, Trade Desk Inc, and Eventbrite Inc.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cardlytics Inc with a $24 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $28.29 and a one-year low of $9.80. Currently, Cardlytics Inc has an average volume of 163.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel.
